Lmr Partners LLP Gracell Biotechnologies Inc. Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.43 - $10.04 $61,928 - $255,869
25,485 Added 5.26%
510,001 $5.12 Million
Q3 2023

Nov 14, 2023
BUY
$2.83 - $4.9 $889,984 - $1.54 Million
314,482 Added 184.95%
484,516 $1.4 Million
Q2 2023

Aug 14, 2023
BUY
$1.45 - $6.07 $123,047 - $515,100
84,860 Added 99.63%
170,034 $647,000
Q1 2023

May 15, 2023
BUY
$1.8 - $2.5 $153,313 - $212,935
85,174 New
85,174 $158,000

Others Institutions Holding GRCL

# of Institutions
2
Shares Held
75.1K
Call Options Held
0
Put Options Held
0
View Full List

About Gracell Biotechnologies Inc.

GRCL Quotes by TradingView
  • Ticker GRCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,674,096
  • Description
  • Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...
More about GRCL
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email